专利摘要:
This invention relates to biotechnology and relates to the preparation of substances that are immunosuppressants of cellular immunity. For the preparation of substances 55185RP and 59451RP, which are cyclodepsipeptides, the strain STREPTOMYCES SP is used. CBS N 162.86 isolated from a soil sample. The strain is cultured in a nutrient medium containing sources of nitrogen, carbon, and mineral salts under deep aerobic conditions. The culture fluid is separated, the mycelium is separated and extracted with an organic solvent. The extract obtained is separated by chromatography and the desired products are purified. 1 tab.
公开号:SU1535383A3
申请号:SU874202611
申请日:1987-05-21
公开日:1990-01-07
发明作者:Декамп Морис;Флош Франсуа;Жюнг Жерар;Марграфф Родольф
申请人:Рон-Пуленк Санте (Фирма);
IPC主号:
专利说明:

Agaric Melanin Vax-manna
Difco Nutritious Broth
Is bad
Average
Agazirovanna
with casein Good
Tyrosine agazirovanna
Yellowish light None None
Flake white cotton culture
Yellowish white to brownish yellow plentiful and folded
Yellowish white folded
 and
Whitish, very weak development
 and
Whitish, very weak development
Average
Good
Whitish
Yellowish segmented well developed
Missing
White abundant
37% skim milk
Compiled by G. Smirnov Editor V. Petrash Tehred M. Khodanych Corrector S. Cherni
Order 58
Circulation 467
VNIIPI State Committee for Inventions and Discoveries at the State Committee on Science and Technology of the USSR 113035, Moscow, Zh-35, Raushsk nab. 4/5
Production and publishing plant Patent, Uzhgorod, st. Gagarin, 101
Segmental brownish quite well developed.
Subscription
权利要求:
Claims (1)
[1]
Claim
A method of obtaining biologically Ak, 55185 tive substances RP and RP 59451, having immunosuppressive action, of the general formula wherein X-Cl (substance 55185 RP) or H (Compound 59451 RP), comprising: r that strain Streptomyces sp. CBS No. 162.86 is cultivated in a nutrient medium containing sources of nitrogen, carbon and mineral salts, under deep aerobic conditions, followed by separation of the mycelium, extraction with an organic solvent, chromatographic separation and purification of the target products.
I I
---------------- - --------------- 4Cultural Power Vegetative Air system Soluble Wednesday development mycelium or topic (consisting of pigmenttowards from environment bathing aerial mice lia and sporulation) 1 2 3 4 5 •_ __________JI S P Good Yellowish white pleated Is absent ____ -Is absent IS P 2 Brown beige Whitish with pleated trace level ny debatable 1 S P }Average White, grayish Is absent I S R. Highly Beige yellow Numerousgood cotton ny folded Beige pink I S Pj Weak Beige, grayishfolded Is absent - I s Enough Whitish abundance - ”-good foldedI S 1 ’ Also Pleated whiteEasy to growyellowishbrownish red pigment Agarized Melanin Wax manna Bad Yellowish light Is absent Is absent Difco Nitrate Nutrient Broth Average Flaky white-cotton culture - - Agate - n - with casein Good Yellowish white to brownish yellow profuse and pleated Tyrosine Aggravated _ m Yellowish b Whitish, _and_folded very weak development
Culture on a pure 12%
gelatin Average Whitish Is absent 28 ° C Good Yellowish, segmented, good White low mobility
sho developed
thirteen 1535383 14Table continuation 11 1 3 4 S The removed skim milk 37 C _ and - The segmented brownish is well developed. Is absent
类似技术:
公开号 | 公开日 | 专利标题
KR860002576A|1986-04-26|Process for preparing new antibiotic compound
SU1535383A3|1990-01-07|Method of producing biologically active substances 55185 rp and 59451 rf possessing immunodepressive effect
TAKASE et al.1984|Amauromine, a new vasodilator taxonomy, isolation and characterization
US4038384A|1977-07-26|Antibiotic a-28086 and process for production thereof
US3801464A|1974-04-02|Antibiotic a16886 and process for production thereof
US4123612A|1978-10-31|7-|-3-|-3-cephem-4-carboxylic acid
US5942619A|1999-08-24|Quinolone compounds for the treatment of disorders caused by helicobacter pylori
US3992551A|1976-11-16|Antisiotic substances B-41, their production and their use as insecticides acaricides
US4174390A|1979-11-13|Antibiotic A-7413 and process for preparation thereof
US3824305A|1974-07-16|Antibiotic a-287 and process for production thereof
US3674774A|1972-07-04|Pyrazomycin and process for production thereof
Sakagami et al.1958|Latumcidin, a new antibiotic from Streptomyces sp.
US3992552A|1976-11-16|Antibiotic substance B-41, their production and their use as insecticides and acaricides
US4083963A|1978-04-11|Polypeptide antibiotic produced by a new subspecies of streptosporangium
US4613503A|1986-09-23|Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US5089530A|1992-02-18|Novel fermentation product with antiparasitic activity
CA1104958A|1981-07-14|Polycyclic ether antibiotic produced by a strain of streptomyces hygroscopicus
US3070514A|1962-12-25|Process for the manufacture of 6-demethyltetracycline
CA1046965A|1979-01-23|Naphthyridinomycin antibiotics from streptomyces
US4173702A|1979-11-06|7-|-3-|-7-methoxy-3-cephem-4-carboxylic acid
CA1090728A|1980-12-02|Antibiotic a-7413 mixture comprising factors a,b,c and d and a process for producing it
US4859599A|1989-08-22|Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
JP2868237B2|1999-03-10|Novel bioactive substance OM-6519 and production method thereof
US4191763A|1980-03-04|Antibiotic A16886 and process for production thereof
US4132790A|1979-01-02|Antibiotic A16886II
同族专利:
公开号 | 公开日
ZA873638B|1987-11-17|
DK258487A|1987-11-23|
FI872235A0|1987-05-21|
PT84933A|1987-06-01|
PT84933B|1989-07-20|
FI872235A|1987-11-23|
FR2599039A1|1987-11-27|
DK258487D0|1987-05-21|
EP0246975A1|1987-11-25|
NO872130L|1987-11-23|
AU592186B2|1990-01-04|
US4810692A|1989-03-07|
AU7324087A|1987-11-26|
FR2599039B1|1988-08-05|
KR870011153A|1987-12-21|
JPS6354395A|1988-03-08|
NO872130D0|1987-05-21|
NZ220379A|1989-02-24|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

US4355112A|1977-06-06|1982-10-19|Sanraku-Ocean Co., Ltd.|Streptomyces culture|CA2059380A1|1991-01-24|1992-07-25|Yiu-Kuen T. Lam|Endothelin receptor antagonists isolated from microbispora|
GB2266890A|1992-04-17|1993-11-17|Merck & Co Inc|Antihypertensive compounds by dechlorination of cyclic depsipeptides|
US5240910A|1992-04-17|1993-08-31|Merck & Co., Inc.|Antihypertensive compounds produced by fermentation|
AU2002322720B2|2001-07-25|2008-11-13|Raptor Pharmaceutical Inc.|Compositions and methods for modulating blood-brain barrier transport|
WO2006115509A2|2004-06-24|2006-11-02|Novartis Vaccines And Diagnostics Inc.|Small molecule immunopotentiators and assays for their detection|
JP2008539047A|2005-04-28|2008-11-13|プロテウスバイオメディカルインコーポレイテッド|Pharma Informatics System|
WO2008036682A2|2006-09-18|2008-03-27|Raptor Pharmaceutical Inc.|Treatment of liver disorders by administration of receptor-associated protein -conjugates|
US20100022568A1|2006-04-13|2010-01-28|Actelion Pharmaceeuticals Ltd.|Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis|
US20120077778A1|2010-09-29|2012-03-29|Andrea Bourdelais|Ladder-Frame Polyether Conjugates|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
FR8607269A|FR2599039B1|1986-05-22|1986-05-22|NEW IMMUNO-SUPPRESSIVE SUBSTANCE, ITS PREPARATION BY CULTURE OF STREPTOMYCES SP.AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT|
[返回顶部]